Earnings Feed
Start Free
Anebulo Pharmaceuticals, Inc.·4

Apr 7, 9:41 PM ET

SHAH BIMAL R. 4

4 · Anebulo Pharmaceuticals, Inc. · Filed Apr 7, 2025

Insider Transaction Report

Form 4
Period: 2025-04-04
Anebulo Pharmaceuticals, Inc.ANEB
SHAH BIMAL R.
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-04-04+25,000→ 25,000 total
    Exercise: $1.02Exp: 2035-04-03→ Common Stock (25,000 underlying)
  • Award

    Stock Option (right to buy)

    2025-04-04+6,618→ 6,618 total
    Exercise: $1.02Exp: 2035-04-03→ Common Stock (6,618 underlying)
Footnotes (1)
  • [F1]The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.

Documents

2 files